BACKGROUND AND PURPOSE: Neurologic and developmental outcomes of asphyxiated, term neonates are difficult to predict applying clinical or laboratory criteria. In this study, we investigated the association of MR spectroscopy (MRS) results with neurodevelopmental status at age 12 months. METHOD: Thirty-one term neonates, who were enrolled in a prospective study of the utility of MR imaging for the determination of neurologic and developmental status, underwent single-voxel proton MRS of the basal nuclei and intervascular boundary zones. Ratios of lactate, choline, creatine, and N-acetylaspartate (NAA) peaks were calculated and tested for association with neuromotor scores and Mental Development Index of the Bayley Scores of Infant Development obtained at age 12 months. RESULTS: Elevated lactate and diminished NAA were the most common findings in infants with neurologic and developmental abnormalities at age 12 months. Although many ratios had statistically significant associations with outcome (P<.05), the highest significance was obtained with lactate/choline ratios in the basal nuclei. A false-positive finding was seen in a patient who was born after a 36-week gestation period (high lactate/choline but normal neurodevelopmental status at 12 months) and in three patients with apparent watershed injury (high watershed lactate/choline but normal neurodevelopmental status at 12 months). A false-negative MRS finding (normal lactate/choline but abnormal outcome) was seen in a patient who had an apparent prenatal injury. CONCLUSION: Proton MRS appears to be a useful tool for assessing brain injury in neonates who have suffered hypoxia or ischemia. Correlation with gestational age and imaging findings are essential for proper interpretation of the spectra. Patients with apparent watershed injuries may have normal neurodevelopmental status at age 12 months.
BACKGROUND AND PURPOSE: Neurologic and developmental outcomes of asphyxiated, term neonates are difficult to predict applying clinical or laboratory criteria. In this study, we investigated the association of MR spectroscopy (MRS) results with neurodevelopmental status at age 12 months. METHOD: Thirty-one term neonates, who were enrolled in a prospective study of the utility of MR imaging for the determination of neurologic and developmental status, underwent single-voxel proton MRS of the basal nuclei and intervascular boundary zones. Ratios of lactate, choline, creatine, and N-acetylaspartate (NAA) peaks were calculated and tested for association with neuromotor scores and Mental Development Index of the Bayley Scores of Infant Development obtained at age 12 months. RESULTS: Elevated lactate and diminished NAA were the most common findings in infants with neurologic and developmental abnormalities at age 12 months. Although many ratios had statistically significant associations with outcome (P<.05), the highest significance was obtained with lactate/choline ratios in the basal nuclei. A false-positive finding was seen in a patient who was born after a 36-week gestation period (high lactate/choline but normal neurodevelopmental status at 12 months) and in three patients with apparent watershed injury (high watershed lactate/choline but normal neurodevelopmental status at 12 months). A false-negative MRS finding (normal lactate/choline but abnormal outcome) was seen in a patient who had an apparent prenatal injury. CONCLUSION: Proton MRS appears to be a useful tool for assessing brain injury in neonates who have suffered hypoxia or ischemia. Correlation with gestational age and imaging findings are essential for proper interpretation of the spectra. Patients with apparent watershed injuries may have normal neurodevelopmental status at age 12 months.
Authors: A J Barkovich; B L Hajnal; D Vigneron; A Sola; J C Partridge; F Allen; D M Ferriero Journal: AJNR Am J Neuroradiol Date: 1998-01 Impact factor: 3.825
Authors: E B Cady; J Penrice; P N Amess; A Lorek; M Wylezinska; R F Aldridge; F Franconi; J S Wyatt; E O Reynolds Journal: Magn Reson Med Date: 1996-12 Impact factor: 4.668
Authors: J D Hanrahan; J Sargentoni; D Azzopardi; K Manji; F M Cowan; M A Rutherford; I J Cox; J D Bell; D J Bryant; A D Edwards Journal: Pediatr Res Date: 1996-04 Impact factor: 3.756
Authors: C Kuenzle; O Baenziger; E Martin; L Thun-Hohenstein; M Steinlin; M Good; S Fanconi; E Boltshauser; R H Largo Journal: Neuropediatrics Date: 1994-08 Impact factor: 1.947
Authors: J Penrice; E B Cady; A Lorek; M Wylezinska; P N Amess; R F Aldridge; A Stewart; J S Wyatt; E O Reynolds Journal: Pediatr Res Date: 1996-07 Impact factor: 3.756
Authors: J D Hanrahan; I J Cox; A D Edwards; F M Cowan; J Sargentoni; J D Bell; D J Bryant; M A Rutherford; D Azzopardi Journal: Pediatr Res Date: 1998-09 Impact factor: 3.756
Authors: D B Vigneron; A J Barkovich; S M Noworolski; M von dem Bussche; R G Henry; Y Lu; J C Partridge; G Gregory; D M Ferriero Journal: AJNR Am J Neuroradiol Date: 2001-08 Impact factor: 3.825
Authors: Duan Xu; Sonia L Bonifacio; Natalie N Charlton; Charles P Vaughan; Ying Lu; Donna M Ferriero; Daniel B Vigneron; A James Barkovich Journal: J Magn Reson Imaging Date: 2011-02 Impact factor: 4.813
Authors: Jessica L Wisnowski; Rafael C Ceschin; So Young Choi; Vincent J Schmithorst; Michael J Painter; Marvin D Nelson; Stefan Blüml; Ashok Panigrahy Journal: Neuroradiology Date: 2015-02-10 Impact factor: 2.804
Authors: Kyle J Steinman; Maria Luisa Gorno-Tempini; David V Glidden; Joel H Kramer; Steven P Miller; A James Barkovich; Donna M Ferriero Journal: Pediatrics Date: 2009-03 Impact factor: 7.124